Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Praphan Phanuphak

Showing results (121-130 of 241) with videos related to

Pageof 25
Sort By:
AIDS Care|February 5, 2017
A qualitative study of Thai HIV-positive young men who have sex with men and transgender women demonstrates the need for eHealth interventions to optimize the HIV care continuumTarandeep Anand, Chattiya Nitpolprasert, Stephen J Kerr, et al.
Journal of the International AIDS Society|December 30, 2021
Same-day antiretroviral therapy initiation hub model at the Thai Red Cross Anonymous Clinic in Bangkok, Thailand: an observational cohort studyPich Seekaew, Nittaya Phanuphak, Nipat Teeratakulpisarn, et al.
AIDS Research and Therapy|November 28, 2012
Association of APOBEC3G genotypes and CD4 decline in Thai and Cambodian HIV-infected children with moderate immune deficiencyTorsak Bunupuradah, Mayumi Imahashi, Thatri Iampornsin, et al.
Journal of Virus Eradication|August 3, 2016
Low incidence of HIV infection in an anonymous HIV counselling and testing clinic cohort in Bangkok, Thailand despite high HIV prevalence and self-report of high-risk behaviourNittaya Phanuphak, Robert Paris, Donn Colby, et al.
Antiviral Therapy|February 5, 2008
Relationships between drug exposure, changes in metabolic parameters and body fat in HIV-infected patients switched to a nucleoside sparing regimenReshma S Autar, Mark A Boyd, Ferdinand W M N Wit, et al.
Plos One|November 9, 2013
HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-line antiretroviral therapyAllison Martin, Cecilia L Moore, Patrick W G Mallon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2011
HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring StudySomnuek Sungkanuparph, Rebecca Oyomopito, Sunee Sirivichayakul, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 26, 2012
Using tuberculin skin test as an entry point to screen for latent and active tuberculosis in Thai people living with HIVNittaya Phanuphak, Jay K Varma, Wanitchaya Kittikraisak, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 4, 2003
Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjectsMark A Boyd, Rob E Aarnoutse, Kiat Ruxrungtham, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2021
Factors Associated With and Characteristic of HIV/Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial ParticipantsRebecca T Henry, Awachana Jiamsakul, Matthew Law, et al.
Pageof 25

Showing results (121-130 of 241) with videos related to

Sort By:
Pageof 25
AIDS Care|February 5, 2017
A qualitative study of Thai HIV-positive young men who have sex with men and transgender women demonstrates the need for eHealth interventions to optimize the HIV care continuumTarandeep Anand, Chattiya Nitpolprasert, Stephen J Kerr, et al.
Journal of the International AIDS Society|December 30, 2021
Same-day antiretroviral therapy initiation hub model at the Thai Red Cross Anonymous Clinic in Bangkok, Thailand: an observational cohort studyPich Seekaew, Nittaya Phanuphak, Nipat Teeratakulpisarn, et al.
AIDS Research and Therapy|November 28, 2012
Association of APOBEC3G genotypes and CD4 decline in Thai and Cambodian HIV-infected children with moderate immune deficiencyTorsak Bunupuradah, Mayumi Imahashi, Thatri Iampornsin, et al.
Journal of Virus Eradication|August 3, 2016
Low incidence of HIV infection in an anonymous HIV counselling and testing clinic cohort in Bangkok, Thailand despite high HIV prevalence and self-report of high-risk behaviourNittaya Phanuphak, Robert Paris, Donn Colby, et al.
Antiviral Therapy|February 5, 2008
Relationships between drug exposure, changes in metabolic parameters and body fat in HIV-infected patients switched to a nucleoside sparing regimenReshma S Autar, Mark A Boyd, Ferdinand W M N Wit, et al.
Plos One|November 9, 2013
HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-line antiretroviral therapyAllison Martin, Cecilia L Moore, Patrick W G Mallon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2011
HIV-1 drug resistance mutations among antiretroviral-naive HIV-1-infected patients in Asia: results from the TREAT Asia Studies to Evaluate Resistance-Monitoring StudySomnuek Sungkanuparph, Rebecca Oyomopito, Sunee Sirivichayakul, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 26, 2012
Using tuberculin skin test as an entry point to screen for latent and active tuberculosis in Thai people living with HIVNittaya Phanuphak, Jay K Varma, Wanitchaya Kittikraisak, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 4, 2003
Pharmacokinetics of indinavir/ritonavir (800/100 mg) in combination with efavirenz (600 mg) in HIV-1-infected subjectsMark A Boyd, Rob E Aarnoutse, Kiat Ruxrungtham, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 5, 2021
Factors Associated With and Characteristic of HIV/Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial ParticipantsRebecca T Henry, Awachana Jiamsakul, Matthew Law, et al.
Pageof 25